Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAILOR-PCI: Genotype-Guided Antiplatelet Therapy
NCT01742117Phase 4Completed
- Sponsor
- Mayo Clinic
- Start
- May 2013
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 4 trial of ticagrelor in coronary artery disease (CAD), acute coronary syndrome (ACS), sponsored by Mayo Clinic. Started May 2013; status: completed.
02
Drugs
ticagrelor
03
Conditions
coronary artery disease (CAD)acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT01742117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01742117.